Legend Biotech Corporation vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
5.9
Neutral
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
LEGN
Consensus analyst target of $57.23 is 143% above current price.
⚠ currently unprofitable (-29% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $57.23 (+142.6%)
16 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
LEGN
PFE
—
Trailing P/E
19.4×
20.5×
Forward P/E
9.4×
-28.8%
Profit Margin
12.4%
20.0%
Gross Margin
75.8%
-29.1%
ROE
8.9%
64.2%
Revenue Growth
-1.2%
—
Earnings Growth
—
0.08
Beta
0.39
—
Price / Book
—
$4.4B
Market Cap
$149.8B
$16 – $45
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →